211 companies

CSPC Pharmaceutical Group

Market Cap: HK$96.2b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$8.40

7D

-0.4%

1Y

-1.9%

Mineralys Therapeutics

Market Cap: US$2.4b

A biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

MLYS

US$27.52

7D

0.9%

1Y

106.3%

Cogent Biosciences

Market Cap: US$6.5b

A clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases.

COGT

US$39.64

7D

2.9%

1Y

218.4%

Tarsus Pharmaceuticals

Market Cap: US$2.4b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

New

TARS

US$57.26

7D

2.0%

1Y

35.2%

China Resources Double-Crane PharmaceuticalLtd

Market Cap: CN¥17.6b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062

CN¥17.16

7D

-0.5%

1Y

-11.0%

Xiamen Amoytop Biotech

Market Cap: CN¥24.6b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥59.36

7D

1.5%

1Y

-21.9%

InventisBio

Market Cap: CN¥15.0b

A clinical stage biotech company, focuses on areas of oncology, autoimmune diseases, and metabolic disorders to address unmet medical needs in China.

New

688382

CN¥25.56

7D

1.0%

1Y

-42.7%

Joincare Pharmaceutical Group IndustryLtd

Market Cap: CN¥18.5b

Joincare Pharmaceutical Group Industry Co.,Ltd.

600380

CN¥10.48

7D

-0.4%

1Y

-14.4%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥41.6b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥25.16

7D

-0.2%

1Y

-20.4%

BGI Genomics

Market Cap: CN¥14.1b

Engages in the provision of research services, comprehensive precision medicine testing solutions, and health management services in China and internationally.

300676

CN¥37.49

7D

0.3%

1Y

-26.9%

Laurus Labs

Market Cap: ₹860.1b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹1,577.80

7D

1.5%

1Y

91.8%

Genscript Biotech

Market Cap: HK$32.1b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

1548

HK$15.62

7D

5.4%

1Y

-14.0%

Keymed Biosciences

Market Cap: HK$25.6b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China, the United States, and the United Kingdom.

2162

HK$83.60

7D

-4.0%

1Y

44.1%

LigaChem Biosciences

Market Cap: ₩3.4t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

A141080

₩93,900.00

7D

-15.4%

1Y

-34.9%

InSilico Medicine Cayman TopCo

Market Cap: HK$25.3b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

3696

HK$45.44

7D

-10.9%

1Y

n/a

Ipca Laboratories

Market Cap: ₹456.4b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.

IPCALAB

₹1,788.50

7D

-4.8%

1Y

22.5%

Dr. Reddy's Laboratories

Market Cap: ₹1.0t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

500124

₹1,183.00

7D

-3.8%

1Y

-5.2%

Laboratorios Farmaceuticos Rovi

Market Cap: €2.8b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€54.70

7D

2.0%

1Y

3.4%

Veradermics

Market Cap: US$4.4b

A clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.

MANE

US$109.49

7D

-0.6%

1Y

n/a

Agios Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

AGIO

US$37.36

7D

-6.4%

1Y

-5.8%

Crinetics Pharmaceuticals

Market Cap: US$8.8b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

CRNX

US$83.90

7D

0.2%

1Y

175.4%

Pharmaron Beijing

Market Cap: CN¥65.5b

Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

300759

CN¥39.76

7D

-1.3%

1Y

46.2%

Yuhan

Market Cap: ₩5.2t

Operates as a pharmaceutical company in South Korea and internationally.

A000100

₩70,700.00

7D

1.7%

1Y

-43.5%

WuXi AppTec

Market Cap: CN¥376.3b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

603259

CN¥125.90

7D

-4.3%

1Y

49.8%

United Laboratories International Holdings

Market Cap: HK$18.1b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

3933

HK$9.22

7D

-0.1%

1Y

-42.9%

Walvax Biotechnology

Market Cap: CN¥21.8b

Engages in the research and development, manufacture, and distribution of vaccines in China and internationally.

300142

CN¥13.49

7D

-2.2%

1Y

16.5%

Gland Pharma

Market Cap: ₹409.0b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

GLAND

₹2,439.10

7D

-1.1%

1Y

19.7%

WuXi XDC Cayman

Market Cap: HK$70.7b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$54.75

7D

-12.6%

1Y

2.1%

Grand Pharmaceutical Group

Market Cap: HK$18.6b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

512

HK$5.32

7D

1.1%

1Y

-43.4%

Haw Par

Market Cap: S$3.6b

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.

H02

S$16.22

7D

-3.6%

1Y

26.8%

Hangzhou Tigermed Consulting

Market Cap: CN¥39.7b

Provides contract research organization services in the People’s Republic of China and internationally.

300347

CN¥49.29

7D

-5.0%

1Y

-14.4%

Page 6 of 6